2018 American Society of Clinical Oncology Annual Meeting*

ASCO 2018 Program Image
Download All
June 1-5, 2018; Chicago, Illinois
Thomas Stinchcombe, MD, and Anne S. Tsao, MD, review and share their expert perspectives on key findings in lung cancer presented at the 2018 ASCO annual meeting.
Thomas Stinchcombe, MD
Anne S. Tsao, MD

Lung Cancer

Slidesets LIBRETTO-001: Phase I Trial of LOXO-292, a Novel RET Inhibitor, in Patients With RET-Altered Advanced Solid Tumors
Slidesets KEYNOTE-407: Phase III Trial of Carboplatin + Paclitaxel/Nab-Paclitaxel ± Pembrolizumab in Patients With Untreated Stage IV Squamous NSCLC
Slidesets LUN 14-179: Phase II Trial of Concurrent Chemoradiation Followed by Consolidation Pembrolizumab in Unresectable Stage III NSCLC
Slidesets DREAM: Phase II Trial of First-line Combination Durvalumab Plus Chemotherapy in Advanced Mesothelioma
Slidesets Phase II KEYNOTE 158: Pembrolizumab in Advanced Small-Cell Lung Cancer
Slidesets CheckMate 227: First-line Nivolumab + CT vs Nivolumab + Ipilimumab vs CT in Patients With NSCLC and < 1% PD-L1 Expression
Slidesets IMpower150 Interim OS Analysis: Atezolizumab + CT ± Bevacizumab vs CT + Bevacizumab in Patients With Untreated Advanced Nonsquamous NSCLC
Slidesets Dacomitinib vs Gefitinib in Advanced NSCLC With EGFR-Activating Mutations: Final OS Analysis From the Phase III ARCHER 1050 Trial
Slidesets KEYNOTE-042: First-line Pembrolizumab vs Platinum-Based Chemotherapy for Advanced or Metastatic NSCLC With PD-L1 TPS ≥ 1%
Slidesets CCGA: Interim Analysis of Observational Study to Detect Early-Stage Lung Cancer Noninvasively via Genomewide Sequencing of Plasma Cell-Free DNA
Slidesets IMpower131: First-line Atezolizumab + Carboplatin/Pac or nab-Pac vs Carboplatin/nab-Pac in Advanced Squamous NSCLC

Review expert insights on key lung cancer presentations from the ASCO 2018 annual meeting in Chicago.

Thomas Stinchcombe, MD Anne S. Tsao, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Released: August 17, 2018 Expired: No longer available for credit
Jointly provided by Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ACHS Logo
Contact Info

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Supported by educational grants from
Amgen
Astellas
AstraZeneca
Celgene Corporation
Eisai
Genentech
Janssen Therapeutics
Merck & Co., Inc.
Seattle Genetics

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue